Defunct Company
Total Trials
11
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,859
NCT02169336
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2014
Completion: Oct 31, 2014
NCT02284243
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery
Start: Oct 31, 2014
Completion: Jun 30, 2015
NCT02540265
Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery
Start: Aug 31, 2015
Completion: Nov 30, 2015
NCT02675907
Evaluation of N1539 Following Bunionectomy Surgery
Phase: Phase 3
Start: Jan 31, 2016
Completion: Jul 31, 2016
NCT02678286
Evaluation of N1539 Following Abdominoplasty Surgery
Completion: Nov 30, 2016
NCT02720692
Evaluation of N1539 Following Major Surgery
Start: Mar 31, 2016
Completion: May 31, 2017
NCT03323385
Evaluation of Preoperative N1539 in Colorectal Surgery
Start: Oct 24, 2017
Completion: Sep 26, 2018
NCT03348423
Evaluation of DEX-IN During Outpatient Procedures
Start: Nov 15, 2017
Completion: Jan 18, 2018
NCT03434275
Evaluation of Preoperative N1539 in Total Knee Arthroplasty
Start: Feb 19, 2018
Completion: May 21, 2019
NCT05315479
Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery
Phase: Phase 4
Start: Feb 24, 2022
Completion: Jul 7, 2022
NCT05687253
Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery
Start: Oct 25, 2022
Completion: May 8, 2023